Karani Asset Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-14,949
Closed -$592K 36
2021
Q4
$592K Sell
14,949
-110,364
-88% -$5.03M 0.29% 31
2021
Q3
$6.27M Sell
125,313
-2,445
-2% -$133K 3.04% 14
2021
Q2
$7.09M Buy
127,758
+756
+0.6% +$40.3K 3.67% 12
2021
Q1
$5.94M Buy
127,002
+792
+0.6% +$38.4K 3.5% 13
2020
Q4
$5.49M Sell
126,210
-7,758
-6% -$286K 3.25% 9
2020
Q3
$4.9M Buy
133,968
+128,787
+2,486% +$4.37M 3.29% 10
2020
Q2
$151K Buy
+5,181
New +$143K 0.12% 54

Other funds holding HCAT

Karani Asset Management's HCAT Position: Q1 2022 in Review

Karani Asset Management sold out of Health Catalyst (HCAT) in Q1 2022, closing a stake of 14,949 shares — an estimated $592K sold.

Karani Asset Management first reported a position in HCAT in Q2 2020 and held it in 7 quarters. The position peaked at $7.09M in Q2 2021. 185 funds tracked by Wall St. Rank hold HCAT as of Q1 2022.

  • Karani Asset Management reported no remaining Health Catalyst position as of Q1 2022 after selling out during the quarter.
  • Karani Asset Management sold 14,949 Health Catalyst shares in Q1 2022, an estimated $592K.
  • Karani Asset Management first reported a position in Health Catalyst in Q2 2020 and held it in 7 quarters.
  • Karani Asset Management's Health Catalyst position peaked at $7.09M in Q2 2021.
  • 185 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2022.

Based on Karani Asset Management's 13F filing for Q1 2022, filed 16 May 2022.